Colgate-Palmolive Company (CL) Shares Sold by Osborn Williams & Donohoe LLC

Osborn Williams & Donohoe LLC decreased its stake in Colgate-Palmolive Company (NYSE:CL) by 1.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 29,614 shares of the company’s stock after selling 500 shares during the period. Osborn Williams & Donohoe LLC’s holdings in Colgate-Palmolive were worth $2,195,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Bank of New York Mellon Corp raised its position in shares of Colgate-Palmolive by 0.9% in the first quarter. Bank of New York Mellon Corp now owns 18,821,363 shares of the company’s stock valued at $1,377,537,000 after buying an additional 169,798 shares during the period. First Eagle Investment Management LLC raised its position in shares of Colgate-Palmolive by 2.6% in the first quarter. First Eagle Investment Management LLC now owns 4,782,281 shares of the company’s stock valued at $350,015,000 after buying an additional 122,983 shares during the period. TIAA CREF Investment Management LLC raised its position in shares of Colgate-Palmolive by 84.2% in the first quarter. TIAA CREF Investment Management LLC now owns 4,554,989 shares of the company’s stock valued at $333,380,000 after buying an additional 2,082,262 shares during the period. Legal & General Group Plc raised its position in shares of Colgate-Palmolive by 5.1% in the first quarter. Legal & General Group Plc now owns 4,293,890 shares of the company’s stock valued at $314,276,000 after buying an additional 208,905 shares during the period. Finally, Swiss National Bank raised its position in shares of Colgate-Palmolive by 22.2% in the first quarter. Swiss National Bank now owns 3,667,072 shares of the company’s stock valued at $268,393,000 after buying an additional 666,400 shares during the period. 73.69% of the stock is owned by hedge funds and other institutional investors.

Shares of Colgate-Palmolive Company (CL) traded up 0.763% on Tuesday, hitting $71.995. 1,129,717 shares of the stock traded hands. The stock has a 50-day moving average price of $72.71 and a 200 day moving average price of $72.83. The stock has a market cap of $63.42 billion, a price-to-earnings ratio of 26.754 and a beta of 0.80. Colgate-Palmolive Company has a 12-month low of $63.43 and a 12-month high of $77.27.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting the consensus estimate of $0.72. The firm had revenue of $3.83 billion for the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The company’s revenue for the quarter was down .5% on a year-over-year basis. During the same quarter last year, the firm earned $0.70 earnings per share. On average, analysts anticipate that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 15th. Investors of record on Tuesday, July 18th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.24%. The ex-dividend date of this dividend is Friday, July 14th. Colgate-Palmolive’s payout ratio is presently 59.48%.

CL has been the subject of several research analyst reports. Bank of America Corporation upped their price target on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, May 31st. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target for the company in a research report on Tuesday, July 4th. Jefferies Group LLC assumed coverage on shares of Colgate-Palmolive in a research report on Tuesday, April 18th. They issued a “hold” rating and a $78.00 price objective for the company. BidaskClub lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Saturday, June 24th. Finally, Wells Fargo & Company reissued a “market perform” rating on shares of Colgate-Palmolive in a research report on Monday, July 24th. Two investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $75.82.

In other news, COO Justin Skala sold 74,374 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, July 27th. The shares were sold at an average price of $72.51, for a total value of $5,392,858.74. Following the transaction, the chief operating officer now owns 97,177 shares of the company’s stock, valued at $7,046,304.27. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Dennis J. Hickey sold 73,872 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $71.80, for a total transaction of $5,304,009.60. Following the completion of the transaction, the chief financial officer now directly owns 484,985 shares in the company, valued at approximately $34,821,923. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 217,969 shares of company stock worth $15,710,108. Insiders own 1.02% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.